Please direct all media inquiries to Gina Cella at gcella@ataaction.org or 781-799-3137
Press Release
ATA AND ATA ACTION LAUD DEA FOR ISSUING A SECOND EXTENSION OF THE REMOTE PRESCRIPTION OF CONTROLLED SUBSTANCES FLEXIBILITIES THROUGH 2024
WASHINGTON, DC, OCTOBER 6, 2023 – The American Telemedicine Association and ATA Action have high praise for the Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) for announcing this morning that they are extending the remote...
ATA ACTION SUBMITS RECOMMENDATIONS TO DEA ON CREATING SPECIAL REGISTRATION PROCESS FOR REMOTE PRESCRIBING OF CONTROLLED SUBSTANCES
In response to DEA listening session scheduled for next week regarding updating proposed rules on telehealth WASHINGTON, DC, SEPTEMBER 6, 2023 – ATA Action officially submitted comprehensive recommendations to the Drug Enforcement Administration (DEA) around...
ATA AND ATA ACTION SUBMIT DETAILED COMMENTS IN RESPONSE TO THE CMS CY2024 PHYSICIAN FEE SCHEDULE PROPOSED RULE
WASHINGTON, DC, AUGUST 29, 2023 — The American Telemedicine Association (ATA) and ATA Action submitted comments in response to the Centers for Medicare & Medicaid Services (CMS) CY2024 Physician Fee Schedule (PFS) proposed policy changes for Medicare payments...